Factors related to the knowledge of nursing professionals about pharmacovigilance
DOI:
https://doi.org/10.15253/2175-6783.20202144118Keywords:
Pharmaceutical Preparations; Drug Utilization; Pharmacovigilance; Patient Safety; Nurse Practitioners.Abstract
Objective: to verify the factors related to the knowledge of nursing professionals about pharmacovigilance. Methods: cross-sectional study, carried out with 271 nursing professionals, with university and school level, through convenience sampling. A questionnaire, consisting of two parts, was used: one about the sociodemographic and professional profile, and the other about knowledge in pharmacovigilance and the practice of reporting adverse events related to medications. The data were analyzed in a descriptive and inferential manner, through comparison and correlation tests, considering a significance level of 5%. Results: the knowledge score showed statistical differences in relation to professional training, function performed in the institution and the age of the professionals, while the practice of notifications did not obtain significantly statistical differences. Conclusion: the factors related to the knowledge in pharmacovigilance of nursing professionals were professional training, the role played in the institution and the age of the professionals.
References
Organização Mundial da Saúde. A importância da farmacovigilância [Internet]. 2005 [cited June 24, 2020]. Available from: https://www.paho.org/bra/index.php?option=com_docman&view=download&alias=745-a-importancia-da-farmacovigilancia-5&category_slug=medicamentos-tecnologia-e-pesquisa-075&Itemid=965
Milani ML, Vandresen F. O Programa Nacional de Segurança do Paciente e as implicações nos serviços de saúde como aspecto relevante ao desenvolvimento regional. Desenvolvimento Regional em Debate [Internet]. 2019 [cited June 21, 2020]; 9(1):478-505. Available from: http://www.periodicos.unc.br/index.php/drd/article/view/2089/1171
Oliveira APB, Oliveira ECS, Oliveira RC. Risk ma- nagement reporting and its contribution to patient safety. Cogitare Enferm [Internet]. 2016 [cited Apr 09, 2020];21(4):1-8. Available from: https://revistas.ufpr.br/cogitare/article/view/47078/pdf_en
Martins MAF, Teixeira APCP. Challenges and perspectives in surveillance of post-marketing/use. Vigil Sanit Debate. 2019; 7(4):3-9. doi: https://doi.org/10.22239/2317-269X.01425
Pezato TPJ, Cesaretti MLR. Farmacovigilância hospitalar: importância do treinamento de profissionais na potencialização de suas ações. Rev Fac Ciênc Méd Sorocaba [Internet]. 2015 [cited Apr 09, 2020]; 17(3):134-9. Available from: https://revistas.pucsp.br/RFCMS/article/view/23518
Modesto ACF, Ferreira TXAM, Provin MP, Amaral RG, Lima DM. Reações adversas a medicamentos e farmacovigilância: conhecimentos e condutas de profissionais de saúde de um hospital da rede sentinela. Rev Bras Educ Méd. 2016; 40(3):401-10.doi:http://dx.doi.org/10.1590/1981-52712015v40n3e01502015
Bigi C, Bocci G. The key role of clinical and community health nurses in pharmacovigilance. Eur J Clin Pharmacol. 2017; 73(11):1379-87. doi: https://doi.org/10.1007/s00228-017-2309-0
Siman AG, Cunha SGS, Brito MJM. The practice of reporting adverse events in a teaching hospital. Rev Esc Enferm USP. 2017; 51:e:03243. doi: http://dx.doi.org/10.1590/S1980-220X2016045503243
Clark E, Draper J, Rogers J. Illuminating the process: Enhancing the impact of continuing professional education on practice. Nurse Educ Today. 2015; 35(2):388-34. doi: https://doi.org/10.1016/j.nedt.2014.10.014
Gomes IBS, Santos DCO, Maia SF, Costa AWS. Atitudes e práticas da equipe de enfermagem para a segurança do paciente. Rev Uningá [Internet]. 2019 [cited Apr 23, 2020]; 52(2):14-29. Available from: http://revista.uninga.br/index.php/uninga/article/view/1398/1898
Organização Pan-Americana da Saúde. Rede Pan-Americana de Harmonização da Regulamentação Farmacêutica. Boas práticas de farmacovigilância para as Américas [Internet]. 2011 [cited Apr 23, 2020]. Available from:https://iris.paho.org/bitstream/handle/10665.2/28455/9789275731604_spa.pdf?sequence=1&isAllowed=y
Morrudo EQ, Figueiredo PP, Silveira RS. Erros in medicinal therapy and the consequences for nursing. Rev Pesq Fundam Cuid Online. 2019; 11(1):88-96. doi: https://doi.org/10.9789/2175-5361.2019.v11i1.88-96
Pool IA, Poell RF, Berings MGMC, Cate OT. Strategies for continuing professional development among younger, middle-aged, and older nurses: a biographical approach. Int J Nurs Stud. 2015; 52(5)939-50. doi: https://doi.org/10.1016/j.ijnurstu.2015.02.004
Singh J, Singh Harmanjit, Rohilla R, Kumar R, Gautam CS. Lack of Awareness of Pharmacovigilance among Young Health‑care Professionals in India: An Issue Requiring Urgent Intervention. Int J Appl Basic Med Res. 2019; 8(3):158-63. doi: https://doi.org/10.4103/ijabmr.IJABMR_423_17
Sato AT, Barros JO, Jardim TA, Ratier APP, Lancman S. Processo de envelhecimento e trabalho: estudo de caso no setor de engenharia de manutenção de um hospital público do município de São Paulo, Brasil. Cad Saúde Pública. 2017; 33(10):e00140316. doi: https://doi.org/10.1590/0102-311X00140316
Linhares JE, Pessa SLR, Bortoluzzi SC, Luz RP. Capacidade para o trabalho e envelhecimento funcional: análise sistêmica da literatura utilizando o PROKNOW-C (Knowledge Development Process – Constructivist). Ciênc Saúde Coletiva. 2019; 24(1):53-66. doi: https://doi.org/10.1590/1413-81232018241.00112017
Mota DM, Vigo A, Kuchenbecker RS. Evolution and key elements of the Brazilian pharmacovigilance system: a scoping review beginning with the creation of the Brazilian Health Regulatory Agency. Cad Saúde Pública. 2018; 34(10):e00000218. doi: https://doi.org/10.1590/0102-311X00000218
Martins MAF, Galato D. Irregularities’s drugs marketed in Brazil: an analysis of notifications and sanitary measures from 2012 to 2017. Vigil Sanit Debate. 2018; 6(4):1-11. doi: https://doi.org/10.22239/2317-269x.01165
Varallo FR, Planeta CS, Mastroianni PC. Effectiveness of pharmacovigilance: multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff. Clinics. 2017; 72(1):51-7. doi: https://doi.org/10.6061/clinics/2017(01)09
Angelis A, Pancani L, Steca P, Colaceci S, Giusti A, Tibaldi L, et al. Testing an explanatory model of nurses’ intention to report adverse drug reactions in hospital settings. J Nurs Manag. 2017; 25(4):307-17. doi: https://doi.org/10.1111/jonm.12467
